Nokea
The nurse is planning discharge teaching for a client with type 2 diabetes mellitus who has a new prescription for insulin glargine. Which action should the nurse plan to include in the discharge teaching?
- A. Demonstrate how to select dose based on before meal blood sugar readings.
- B. Provide information on increasing medication dosage if ketoacidosis occurs.
- C. Teach the client self-injection skills for daily subcutaneous administration.
- D. Explain to the family how to inject this medication for severe hypoglycemia.
Correct Answer: C
Rationale: Insulin glargine requires daily subcutaneous administration, so teaching self-injection skills is essential. It’s not dosed based on meal readings, adjusted for ketoacidosis, or used for hypoglycemia.
You may also like to solve these questions
History and physical
POD 5
1015
The client is alert and oriented. Rates her pain a 3 on a 0 to 10 pain scale. The client says that she has fullness in her abdomen. Heart sounds are regular and rhythmic. Pulses 1+ in all extremities and equal. Her last bowel movement was POD 2. Healthcare provider notified. The client voided 150 mL of urine.
1100
Bisacodyl suppository given as prescribed.
Reported slight rectal burning when administered.
Nurses notes
POD 5
1015
The client is alert and oriented. Rates her pain a 3 on a 0 to 10 pain scale. The client says that she has fullness in her abdomen. Heart sounds are regular and rhythmic. Pulses 1+ in all extremities and equal. Her last bowel movement was POD 2. Healthcare provider notified. The client voided 150 mL of urine.
1100
Bisacodyl suppository given as prescribed.
Reported slight rectal burning when administered.
1200
Rates her pain a 7 on a 0 to 10 pain scale. Pulses 1+ in all extremities and equal. Morphine given as prescribed. She asked to use the restroom but felt dizzy. Voided 600 mL urine in the bedpan.
Flowsheet
Vital Signs
POD 5
1015
Temperature 97.2° F (36.2° C) orally
Heart rate 77 beats/minute
Respiratory rate 14 breaths/minute
Blood pressure 119/75 mm Hg
1200
• Temperature 97° F (36.1° C) orally
Review H and P, nurse's notes, flow sheet, and prescriptions. Mark whether the assessment finding represents a therapeutic result of the lactulose administered, a non-therapeutic side-effect, or an unrelated finding. Each row must have only one option selected.
- A. Reported slight rectal burning sensation: Non-therapeutic side effect
- B. Large, soft stool: Therapeutic result
- C. Dizziness: Non-therapeutic side effect
- D. Pain level of 3 on a 0 to 10 pain scale: Unrelated finding
- E. 600ml of urine: Unrelated finding
- F. Abdomen soft and flat: Unrelated finding
- G. Respiratory rate 13 breaths/min: Unrelated finding
Correct Answer:
Rationale: The question refers to bisacodyl, not lactulose. A: Rectal burning is a bisacodyl side effect. B: Soft stool is the therapeutic effect. C: Dizziness may relate to morphine, not bisacodyl. D, E, F, G: Pain, urine output, abdomen, and respiratory rate are unrelated to bisacodyl.
A client with chronic kidney disease (CKD) is receiving calcium acetate 667 mg PO. A decrease in which blood value indicates to the nurse that the medication is having the desired effect?
- A. pH.
- B. Phosphate.
- C. Potassium.
- D. Calcium.
Correct Answer: B
Rationale: Calcium acetate lowers phosphate levels in CKD by binding dietary phosphate. A decreased phosphate level indicates effectiveness. pH, potassium, and calcium are not primary targets.
The nurse prepares to administer a scheduled dose of labetalol PO to a client with hypertension. The client's vital signs are a temperature of 99° F (37.2° C), a heart rate of 48 beats/minute, respirations of 16 breaths/minute, and a blood pressure of 150/90 mm Hg. Which action should the nurse take?
- A. Apply a telemetry monitor before administering the dose.
- B. Assess for orthostatic hypotension before administering the dose.
- C. Administer the dose and monitor the client's blood pressure regularly.
- D. Withhold the scheduled dose and notify the healthcare provider.
Correct Answer: D
Rationale: A heart rate of 48 beats/minute indicates bradycardia, a concern with labetalol (a beta-blocker). Withholding the dose and notifying the provider is appropriate to prevent worsening bradycardia.
History and physical
The client is a 26-year-old female with acute appendicitis. She has a 12 year history of type 1 diabetes mellitus and no other significant medical history. The appendectomy was completed without issue, and the client will be admitted to the surgical floor to recover.
Nurses notes
0730
Admitted the client. She is awake and alert. She rates her pain 2 on a 0 to 10 pain scale. Her pulses are equal bilaterally. Heart rate is 76 beats/minute, normal sinus rhythm. Her oxygen saturation is 100% on room air. She has a gauze dressing over her surgical site, which is clean and dry. Her temperature is 98.5° F (37.0° C) orally. She urinated 50 mL upon arrival in the unit and is reporting she
Lab results
Blood glucose 279mg/dl
Orders
Admit to the surgical floor
• Dextrose 5% and 0.9% sodium chloride IV to infuse at 125 mL/hr
Advance diet as tolerated
• Insulin glargine 12 units SUBQ every 24 hours
. Ceftriaxone 2 gram IV piggy back (IVPB) every
24 hours for 3 days, first dose given in surgery
The nurse prepares to give 2 units of insulin lispro. Which should the nurse double check with a second nurse? Select all that apply.
- A. The dose of insulin drawn up in the syringe
- B. The expiration date on the insulin vial
- C. The type of insulin to be administered
- D. The sliding scale insulin lispro prescription
- E. The insulin concentration
- F. The insulin vial for color and clarity
- G. The history and physical with the diabetes diagnosis listed
Correct Answer: A,B,C,D,E,F
Rationale: Dose, type, prescription, concentration, vial clarity, and expiration ensure safe insulin administration. B and G are standard nurse assessments, not requiring double-checking.
A client with chronic asthma receives a prescription for montelukast, a leukotriene modifier. Which statement by the client indicates to the nurse that medication teaching was effective?
- A. I should take this medication only when I am having an asthma attack.
- B. I will not need to use my inhalers twice a day when I start this medicine.
- C. This medication will stop an asthma attack immediately.
- D. I will take the tablet every evening to control my asthma.
Correct Answer: D
Rationale: Montelukast is a maintenance medication taken regularly (often in the evening) to control asthma. It is not for acute attacks or to replace inhalers, indicating the client understands its role.